Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease
Clinical Trial Phase I / II Prospective, Open, Non-randomized for Treatment of Lumbar Intervertebral Degenerative Disc Disease With Posterolateral Instrumented and Autologous Mesenchymal Stem Cells.
Sponsor: Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán
Listed as NCT01513694, this PHASE1/PHASE2 trial focuses on Intervertebral Disc Disease and remains completed. Sponsored by Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jun 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
Status: Unknown Status → Completed
▶ Show 1 earlier version
-
Jan 2017 — Jun 2017 [monthly]
Unknown Status PHASE1_PHASE2
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán
- Red de Terapia Celular
- Spanish National Health System
For direct contact, visit the study record on ClinicalTrials.gov .